Belite Bio (BLTE) Shares Outstanding (Diluted Average) (2020 - 2025)

Belite Bio's Shares Outstanding (Diluted Average) history runs 6 years deep, the most recent figure standing at $33.5 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 9.82% year-over-year to $33.5 million; the TTM figure through Dec 2025 stood at $33.5 million (up 9.82% YoY), while the FY2025 annual figure was $33.5 million, up 9.82% from the prior year.
• Shares Outstanding (Diluted Average) was $33.5 million for Q4 2025 at Belite Bio, up from $30.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $33.5 million in Q4 2025 to a low of $9.6 million in Q4 2021.
• Historically, Shares Outstanding (Diluted Average) has averaged $24.0 million across 5 years, with a median of $26.6 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Diluted Average) climbed 8.87% in 2021, then jumped 108.74% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $9.6 million in 2021, then jumped by 108.74% to $20.0 million in 2022, then jumped by 33.12% to $26.6 million in 2023, then gained by 14.83% to $30.5 million in 2024, then grew by 9.82% to $33.5 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $33.5 million (Q4 2025), $30.5 million (Q4 2024), and $26.6 million (Q4 2023), per Business Quant data.